Prevalence of Epstein-Barr virus in Japan: trends and future prediction.
about
Immune modulation during latent herpesvirus infectionPhase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisInfectious MononucleosisThe role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differencesEnvironmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsThe long and evolving relationship between viruses and multiple sclerosisViral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data.Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016.Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.A large-scale seroprevalence of Epstein-Barr virus in Taiwan.Diffuse Large B-cell Lymphoma Arising from Chronic Tuberculous Empyema.The initiation and prevention of multiple sclerosis.The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections.Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control?Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.Prospective studies of infectious mononucleosis in university students.The levels of liver enzymes and atypical lymphocytes are higher in youth patients with infectious mononucleosis than in preschool children.High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts.Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.The role of epidemiology in MS research: Past successes, current challenges and future potential.Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes.Epstein-Barr virus and human herpes virus-8 are not associated with juvenile nasopharyngeal angiofibroma.Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus.Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study.Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition.Effective control of Epstein-Barr virus infection following pediatric liver transplantation by monitoring of viral DNA load and lymphocyte surface markers.Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.Epstein-Barr virus-positive lymphoproliferative disorder associated with old organized chronic subdural hematoma.Herpesvirus infections and allergic sensitization in children of families with anthroposophic and non-anthroposophic lifestyle - the ALADDIN birth cohort.Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.Pre-emptive rituximab for Epstein-Barr virus reactivation after haplo-hematopoietic stem cell transplantation.
P2860
Q24624044-ED939566-51F8-487A-9A59-97258864C207Q24657081-25B96BD2-D29D-4E31-AC46-71EEF48E14D0Q26783692-059BDD2D-4D04-4222-8E70-3619E5941249Q26866256-01C6489F-5FBD-485F-8FA4-5B832C132098Q27006548-6D7CDE20-247E-42C1-AD56-F5A20923F50BQ29301310-CC47573B-5303-4A51-B6E7-59E3B695A5E7Q30702069-1BADFE90-1A5E-44D0-A6AD-662E1E93EFE9Q33570474-55B928B4-2FF7-40F1-B2C3-F7E4A9299E45Q34746549-E587D7F6-11DF-46D3-BC74-EB17CF27B094Q35007123-6B9C0F97-5917-48D8-BFE7-DE1CF3E5A59AQ35099439-5A3588C5-D69F-42F4-8738-87A43B9A1494Q35741861-DDC10ACF-0202-4F86-BF74-2A2A6510988DQ36687519-FE5848A4-1D36-4D91-83BE-6F943BBBE72AQ36688962-7B7260AE-CA21-4770-BA74-25D621AEFCEFQ37004820-5C55B125-A45A-45B1-984C-7AD3D1F78EFDQ37223722-51FE5992-ED7A-4369-B5BB-EC84CF2A4EBEQ37488822-BCA90D7F-D106-4EBE-A5DC-6A44D837189BQ37807871-DD4845F9-F914-4558-8B8A-AFC849C15AD9Q38248192-5D4A4348-1171-4B20-B3B8-8AE68DC786E0Q38376270-A79A0084-3043-4F5B-8699-3163CDC1E710Q40220037-D06AAE92-C329-41FE-B517-574C3F50DA80Q42102834-4873E2B3-7E50-4FE6-9EB5-C9C1971AE202Q42209029-B24266ED-1EB6-459F-9D07-B33B0A0C3E62Q42268139-C1AA9B2F-1CA1-49A5-BF5D-4FD82A8E7D72Q42282835-DBC1262D-8844-4B6F-BC3F-BC0A45FD41BDQ43520891-227AB030-DF46-4DBD-B693-3F414C3F562BQ43845119-245FA5DB-506A-4E0E-8E6C-3ED8D9CED892Q45357499-21865A12-4831-4E29-B8CE-D3AAB37F214DQ48315064-14F426B8-A685-48A3-93ED-560382A77CE5Q54264121-166EFF7B-60FE-4FB9-9DB1-D843867045C2Q54379261-60A48241-41DD-43DE-A76D-2B02A259C7E6
P2860
Prevalence of Epstein-Barr virus in Japan: trends and future prediction.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Prevalence of Epstein-Barr virus in Japan: trends and future prediction.
@en
type
label
Prevalence of Epstein-Barr virus in Japan: trends and future prediction.
@en
prefLabel
Prevalence of Epstein-Barr virus in Japan: trends and future prediction.
@en
P2093
P2860
P1476
Prevalence of Epstein-Barr virus in Japan: trends and future prediction.
@en
P2093
Keiko Tanaka-Taya
Kengo Takeuchi
Masashi Fukayama
Shigeo Mori
Shuji Hashimoto
Yoichi M Ito
Yukumasa Kazuyama
P2860
P304
P356
10.1111/J.1440-1827.2006.01936.X
P577
2006-03-01T00:00:00Z